tradingkey.logo
tradingkey.logo
Search

Angiodynamics Announces Two-Year Preserve Trial Data Demonstrating Durable Nanoknife Ire System Outcomes In Intermediate-Risk Prostate Cancer

ReutersMay 13, 2026 1:06 PM
facebooktwitterlinkedin
View all comments0

- AngioDynamics Inc ANGO.O:

  • ANGIODYNAMICS ANNOUNCES TWO-YEAR PRESERVE TRIAL DATA DEMONSTRATING DURABLE NANOKNIFE IRE SYSTEM OUTCOMES IN INTERMEDIATE-RISK PROSTATE CANCER

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

Tradingkey
KeyAI